Professor Paolo Calabro

Contributor content

• Articles

Journal

Sustainable and effective lipid-lowering management: prevention strategies from the BRING-UP prevention study

8 February 2026

See more

Journal

Withdrawing heart failure therapy after AF rhythm control: promise, caution, and perspective

20 January 2026

See more

Journal

Acute pharmacologic management of myocardial infarction in patients undergoing percutaneous coronary intervention: insights from the Italian nationwide EYESHOT-2 prospective registry

25 November 2025

See more

Journal

Early DAPT discontinuation after acute myocardial infarction: finding the optimal TARGET

30 September 2025

See more

Journal

When more is worse: aspirin backfires in anticoagulated post-PCI patients

22 September 2025

See more

Journal

An old drug in a new era: digitoxin in the spotlight after DIGIT-HF

12 September 2025

See more

Journal

Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectives

15 July 2025

See more

Journal

Long-term antiplatelet monotherapy after PCI: searching for the smart choice

26 April 2025

See more

Journal

AZALEA–TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain

10 March 2025

See more

Journal

OCEANIC-AF trial: factor XI inhibitors revolution in atrial fibrillation is on hold

10 September 2024

See more